German biotechnology firm AquaNab has secured an undisclosed investment from Nordic Foodtech VC to advance its pioneering immunotherapy platform for the aquaculture industry. The Hamburg-based company is developing a novel, feed-based treatment using nanoantibodies to combat sea lice in Atlantic salmon. This innovation aims to provide a sustainable and less invasive alternative to current methods, addressing a major challenge in global fish farming.
Tackling a Costly Industry Scourge
Sea lice represent one of the most significant threats to salmon farming, costing the global aquaculture industry an estimated $4 billion annually. These costs stem from direct production losses, fish mortality, and expensive treatment protocols required to manage infestations. The parasite's persistence has made it a primary focus for innovation within the sector as producers seek more effective control measures.
Current delousing methods, which often involve chemical baths or mechanical removal, raise considerable animal welfare and environmental concerns. These treatments can be stressful for the fish and lead to chemical runoff, attracting scrutiny from regulators and consumers alike. Consequently, the industry is actively searching for more sustainable solutions that protect both the fish and the surrounding marine ecosystems.
A Novel Nanoantibody Approach
AquaNab is pioneering a unique solution by using alpaca-derived nanoantibodies, which are exceptionally small and robust antibodies. The company has developed a method to administer these nanoantibodies, branded as AquaNabs, orally through fish feed. This delivery system is a world-first for aquaculture and is designed to eliminate the stress associated with conventional handling and treatments.
The company's research has demonstrated that its nanoantibodies can survive the digestive process and successfully cross the fish's intestinal barrier to enter the bloodstream. This mechanism allows for a targeted immune response against parasites like sea lice from within the fish. The science is backed by co-founder Dr. Alejandro Rojas, who was among the first to develop neutralizing nanoantibodies against SARS-CoV-2.
Strategic Investment for Future Growth
The investment from Nordic Foodtech VC marks a significant milestone for AquaNab and is notably the venture capital firm's first investment outside the Nordic region. This move signals strong confidence in the German startup's potential to disrupt the animal health market. Mika Kukkurainen, a partner at the firm, noted that AquaNab could transform how disease is managed across food production.
According to CEO Dr. Ruth Tamara Montero, the goal is to provide producers a way out of the cycle of costly treatments and production losses. While the initial product targets sea lice in Atlantic salmon, the underlying technology is a versatile platform. It is designed to be adapted to combat a range of bacterial, viral, and parasitic diseases affecting other aquaculture species.
The Path to Commercialization
With this new funding, AquaNab will advance its lead program towards completing its proof of concept. The company also plans to expand its collaborations with key industry players, including salmon producers, feed manufacturers, and animal health companies. These partnerships will be crucial for testing, refining, and eventually commercializing its first products for the market.
Despite the promising technology, AquaNab faces the challenges of scaling a novel biologic treatment for a global industry. The company must navigate the regulatory approval process while demonstrating efficacy and cost-effectiveness at a commercial scale. Success will depend on proving its innovative solution works as effectively in the water as it does in the laboratory.
AquaNab's innovative approach to fish health represents a significant step forward for sustainable aquaculture. By developing a feed-based nanoantibody treatment, the company offers a promising solution to the persistent problem of sea lice. This strategic investment from Nordic Foodtech VC will accelerate its mission to provide effective, welfare-friendly tools that enhance resilience across the entire food production system.